Basic info
Industry
pharmaceutical manufacturing
Sectors
Daiichi Sankyo
tenosynovial giant cell tumor
diabetes
stroke risk reduction
Health Care
acute coronary syndrome
Therapeutics
Inc. is a member of the Daiichi Sankyo Group and is focused on the development of oncology therapies and specialty medicines. Daiichi Sankyo
metastatic melanoma
Wellness
hypertension
thrombosis
IV iron therapy. PP-US-NP-1500 6/21
Inc. medicines approved in the U.S. include therapies for metastatic breast and gastric cancer
dyslipidemia
Date founded
2010